Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: TobagoJack who wrote (60089)	1/19/2010 9:54:36 AM
From: Cogito Ergo Sum	Respond to of 217576

some choices CMH, ZNN, WPT... all Canadian :O) Miles to go and profits to make... before I sleep...

To: TobagoJack who wrote (60089)	1/20/2010 12:08:21 AM
From: energyplay	Read Replies (2) \| Respond to of 217576

The toe cancer idea is a place holder - a sort of nominal disease. Fix toe cancer, and maybe the same drug can effect a couple of the other 276 or so cancers. So we find the toe cancer company, and pick up shares before it becomes obvious that it might work for colon, lung, or skin. Each of those is a several billion dollar market, and even a piece is means several hundred million per year, meaning the stock valuation can be a couple of billion. ***** The various cancers may become vulnerable based on new understandings of gene expression, and other tools. The expansion of cancers is being slowed by drugs which inhibit new blood vessels. There are some targeted therapies that can cause the immune system to attack cancer. Optimistically, we might see 10-30% of the cancer types become treatable/curable in a period of a few years.